Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications.

Drug Des Devel Ther 2015 18;9:4735-49. Epub 2015 Aug 18.

Clinical Investigation Centre, University Malaya Medical Centre, Lembah Pantai, Kuala Lumpur, Malaysia ; Cardiology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Purpose: Cardiovascular disease (CVD) is a macrovascular complication in patients with type 2 diabetes mellitus (T2DM). To date, glycemic control profiles of antidiabetic drugs in cardiovascular (CV) complications have not been clearly elucidated. Therefore, this study was conducted retrospectively to assess the association of antidiabetic drugs and glycemic control with CV profiles in T2DM patients. The association of concurrent medications and comorbidities with glycemic control was also investigated.

Methods: A total of 220 T2DM patients from the University of Malaya Medical Centre, Malaysia, who had at least one CV complication and who had been taking at least one antidiabetic drug for at least 3 months, were included. The associations of antidiabetics, cardiovascular diseases, laboratory parameters, concurrent medications, comorbidities, demographics, and clinical characteristics with glycemic control were investigated.

Results: Sulfonylureas in combination (P=0.002) and sulfonylurea monotherapy (P<0.001) were found to be associated with good glycemic control, whereas insulin in combination (P=0.051), and combination biguanides and insulin therapy (P=0.012) were found to be associated with poor glycemic control. Stroke (P=0.044) was the only type of CVD that seemed to be significantly associated with good glycemic control. Other factors such as benign prostatic hyperplasia (P=0.026), elderly patients (P=0.018), low-density lipoprotein cholesterol levels (P=0.021), and fasting plasma glucose (P<0.001) were found to be significantly correlated with good glycemic control.

Conclusion: Individualized treatment in T2DM patients with CVDs can be supported through a better understanding of the association between glycemic control and CV profiles in T2DM patients.

Download full-text PDF

Source
http://dx.doi.org/10.2147/DDDT.S87294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547657PMC
June 2016
9 Reads

Publication Analysis

Top Keywords

glycemic control
20
antidiabetic drugs
12
type diabetes
8
concurrent medications
8
medications comorbidities
8
control profiles
8
t2dm patients
8
cardiovascular complications
8
diabetes mellitus
8
control
5
220 t2dm
4
total 220
4
patients university
4
university malaya
4
centre malaysia
4
medical centre
4
malaya medical
4
retrospectively assess
4
control investigatedmethods
4
association antidiabetic
4

Similar Publications